Preclinical Characterisation of JNJ-54257099 – A Potent Uridine-Based Nucleotide Polymerase Inhibitor in Phase I Clinical Development for the Treatment of Chronic Hepatitis C von Tambuyzer, L, Vijgen, L, Jonckers, T.H, Lachau-Durand, S, Snoeys, J, Leclercq, L, Berke, J.M, Deval, J, Van Remoortere, P, Simmen, K, De Meyer, S, Raboisson, P

Volltext

THU-261 - Preclinical Characterisation of JNJ-54257099 – A Potent Uridine-Based Nucleotide Polymerase Inhibitor in Phase I Clinical Development for the Treatment of Chronic Hepatit... von Tambuyzer, L., Vijgen, L., Jonckers, T.H., Lachau-Durand, S., Snoeys, J., Leclercq, L., Berke, J.M., Deval, J., Van Remoortere, P., Simmen, K., De Meyer, S., Raboisson, P.

Volltext